Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Chapter 42 Sickle Cell Disease
- Chapter 43 Transfusions
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Chapter 43 - Transfusions
from Subpart IVF - Clinical – Hematologic
Published online by Cambridge University Press: 31 March 2017
Edited by
Book contents
- Observation Medicine
- Observation Medicine
- Copyright page
- Contents
- Advance Praise
- About the Editors
- Contributors
- Foreword: Onward and Upward
- Preface
- Part I Administration: Key Concepts of Observation Medicine, and Developing and Maintaining an Observation Unit
- Part II Observation Medicine: Clinical Setting and Education
- Part III New Developments in Observation Medicine
- Part IV Clinical
- Subpart IVA Clinical – Cardiac
- Subpart IVB Clinical – Respiratory
- Subpart IVC Clinical – Vascular
- Subpart IVD Clinical – Neurologic
- Subpart IVE Clinical – Metabolic, Endocrine
- Subpart IVF Clinical – Hematologic
- Chapter 42 Sickle Cell Disease
- Chapter 43 Transfusions
- Subpart IVG Clinical – Infections
- Subpart IVH Clinical – Gastrointestinal
- Subpart IVI Clinical – Genitourinary
- Subpart IVJ Clinical – Obstetrics and Gynecology
- Subpart IVK Clinical – Pediatrics and Geriatrics
- Subpart IVL Clinical – Surgical Evaluation
- Subpart IVM Clinical – Pain Management and Musculoskeletal
- Subpart IVN Clinical – Trauma
- Subpart IVO Clinical – Toxicology
- Subpart IVP Clinical – Psychosocial
- Subpart IVQ Clinical – Disasters
- Part V Financial
- Part VI International
- Part VII Evidence Basis for Observation Medicine
- Part VIII Clinical Protocols
- Part IX Administrative Policies
- Part X Order Sets
- Prologue
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Observation MedicinePrinciples and Protocols, pp. 250 - 256Publisher: Cambridge University PressPrint publication year: 2017
References
Carson, JL, Grossman, BJ, Kleinman, S, et al. Red Blood cell transfusion: a clinical practice guideline from the AABB. Ann Int Med 2012; 157(1):49–58.CrossRefGoogle Scholar
National Health and Medical Research Council and the Australasian Society of Blood Transfusion. Clinical practice guidelines on blood product utilization [online text]. 2001. Available at: www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp78.pdf?q=publications/synopses/_files/cp78.pdf. Accessed February 20, 2016.Google Scholar
Guidelines for the clinical use of red cell transfusions. British J Haematol, 2001;113: 24–31.CrossRefGoogle Scholar
Viele, MK, Weiskopf, RB. What can we learn about the need for transfusion from patients who refuse blood? The experience with Jehovah’s Witnesses. Transfusion 1994; 43: 396–401.CrossRefGoogle Scholar
Liumbruno, G, Bennardello, F, Lattanzio, A, et al. Recommendations for the transfusion of red blood cells. Blood Transfus 2009, 7:49–64.Google ScholarPubMed
Choo, Y. The HLA system in transfusion medicine. In: McCullough, J, ed. Transfusion Medicine. New York, NY: McGraw–Hill Book Co;1998:401.Google Scholar
Castro, O. Management of sickle-cell disease: recent advances and controversies. Br J Haematology. 1999; 107: 2–11.CrossRefGoogle Scholar
British Committee for Standards in Haematology. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. The British Society for Haematology, 2004; 126: 11–28.CrossRefGoogle Scholar
American Red Cross. Practice Guidelines for Blood Transfusions [online text]. 2nd ed. 2007. Available at: www.redcross.org/www-files/Documents/WorkingWiththeRedCross/practiceguidelinesforbloodtrans.pdf. Accessed January 5, 2012.Google Scholar
Baker, RI, Coughlin, PB, Gallus, AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. MJA 2004; 181: 492–497.Google Scholar
Baker, RI, Coughlin, PB, Gallus, AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis andHaemostasis. MJA 2004; 181: 492–497.Google Scholar
Cushman, M, Lim, W, Zakai, N. American Society of Hematology: Clinical Practice Guide on Anticoagulant Dosing and Management of Anticoagulant-Associated Bleeding Complications in Adults [online text]. 2011. Available at: www.hematology.org/Practice/Guidelines/7243.aspx. Accessed February 20, 2016.Google Scholar
World Federation of Hemophilia. Guidelines for the Management of Hemophilia [online text]. 2013. Available at: www.wfh.org/2/docs/Publications/Diagnosis_and_Treatment/Guidelines_Mng_Hemophilia.pdf. Accessed February 20, 2016.Google Scholar
National Hemophilia Foundation. Medical and Scientific Advisory Council Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders [online text]. 2015. Available at: www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=693. Accessed February 20, 2016.Google Scholar
Ansell, JE. 9th National Conference on Anticoagulant Therapy. Preface. J Thromb Thrombolysis 2008; 25:1.CrossRefGoogle ScholarPubMed
Mannucci, PM. Treatment of von Willebrand’s Disease. N Engl J Med 2004;351:683–694.CrossRefGoogle ScholarPubMed
National Heart, Lung, and Blood Institute The-Diagnosis-Evaluation-and-Management-of-von-Willebrand-Disease- [online text]. 2008. Available at: http://catalog.nhlbi.nih.gov/catalog/product/The-Diagnosis-Evaluation-and-Management-of-von-Willebrand-Disease-Full-Report-/08-5832. Accessed February 20, 2016.Google Scholar
American Society of Hematology: Clinical Practice Guideline on the Evaluation and Management of von Willebrand Disease [online text]. 2012. Available at: www.hematology.org/practice/guidelines/426.aspx. Accessed February 20, 2016.Google Scholar
British Committee for Standards in Haematology. Guidelines for the use of platelet transfusions. The British Society for Haematology, 2003; 122: 10–23.CrossRefGoogle Scholar
Slichter, SJ. Evidence-based platelet transfusion guidelines. American Society of Hematology Education Book. 2007;1:172–178.Google Scholar
American Society of Hematology: Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia [online text]. 2011. Available at: www.hematology.org/Practice/Guidelines/6584.aspx. Accessed February 20, 2016.Google Scholar
Cines, DB, Blanchette, VS. Immune Thrombocytopenic Purpura. N Engl J Med 2002; 346:995–1008.CrossRefGoogle ScholarPubMed
McCullough, J, Refaai, MA, Cohn, CS. Blood Procurement and Red Cell Transfusion. In: Kaushansky K, Lichtman MA, Prchal JT, et al. eds. Williams Hematology. 9th ed. New York: McGraw-Hill; 2016, chapter 138. www.accessmedicine.com.library.ccf.org/content.aspx?aID=6236286. Accessed February 20, 2016.Google Scholar
Vigue, B. Bench-to-bedside review: Optimizing emergency reversal of Vitamin K antagonists in severe haemorrhage – from theory to practice. Crit Care 2009; 13: 209.CrossRefGoogle Scholar